# Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients

> **NCT01049126** · — · COMPLETED · sponsor: **Precision Therapeutics** · enrollment: 76 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

- **OTHER:** ChemoFx

## Key facts

- **NCT ID:** NCT01049126
- **Lead sponsor:** Precision Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-10
- **Final completion:** 2010-02
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2011-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049126, "Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01049126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*